G1 Therapeutics (GTHX) stock forecast for 2026

The forecast has been updated: March 26, 2023 12:23


G1 Therapeutics stock price online today

Analyst Target Price

13.83

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell G1 Therapeutics stock stock today? What is the projected target price level for 2026? How much will it cost in 2026? G1 Therapeutics stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2026.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $13.83 target price for G1 Therapeutics stock stock.

Today 200 Day Moving Average is the resistance level (8.1 $).

50 Day Moving Average is the resistance level (4.929 $).




GTHX Forecast for 2026

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 2.23 2.07 2.64 21.62 %
Feb 2.24 2.04 2.49 17.99 %
Mar 2.60 2.25 2.96 23.97 %
Apr 2.45 2.28 2.68 14.80 %
May 2.35 1.89 2.62 27.82 %
Jun 2.35 2.00 2.83 29.35 %
Jul 2.64 2.43 2.86 14.95 %
Aug 2.65 2.33 2.89 19.34 %
Sep 2.38 2.03 2.80 27.33 %
Oct 2.63 2.35 3.17 25.76 %
Nov 2.39 2.20 2.60 15.41 %
Dec 2.43 2.13 2.82 24.51 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of G1 Therapeutics stock.


G1 Therapeutics overview

G1 Therapeutics Address

79 T.W. ALEXANDER DRIVE, 4501 RESEARCH COMMONS, SUITE 100, RESEARCH TRIANGLE PARK, NC, US

Market Capitalization

132 760 000 $

EBITDA

-135 648 000

PE Ratio

None

PEG Ratio

0

Dividend Per Share

0

Dividend Yield

0

EPS

-2.89

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0.768

Trailing PE

-

Forward PE

-

EV To Revenue

6.04

EV To EBITDA

-1.986

52 Week High

17.49

52 Week Low

2.55

50 Day Moving Average

4.929

200 Day Moving Average

8.1

Shares Outstanding

51658000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

G1 Therapeutics stock forecast for this year


G1 Therapeutics stock forecast for Jan 2026.
Estimated Average Forecasted G1 Therapeutics Price: 2.23. Positive monthly dynamics of the instrument is expected with 21.622% volatility is expected.

Pessimistic forecast: 2.07

Optimistic: 2.64


G1 Therapeutics stock forecast for Feb 2026.
Estimated Average Forecasted G1 Therapeutics Price: 2.24. Positive monthly dynamics of the instrument is expected with 17.989% volatility is expected.

Pessimistic forecast: 2.04

Optimistic: 2.49


G1 Therapeutics stock forecast for Mar 2026.
Estimated Average Forecasted G1 Therapeutics Price: 2.60. Positive monthly dynamics of the instrument is expected with 23.970% volatility is expected.

Pessimistic forecast: 2.25

Optimistic: 2.96


G1 Therapeutics stock forecast for Apr 2026.
Estimated Average Forecasted G1 Therapeutics Price: 2.45. Negative monthly dynamics of the instrument is expected with 14.802% volatility is expected.

Pessimistic forecast: 2.28

Optimistic: 2.68


G1 Therapeutics stock forecast for May 2026.
Estimated Average Forecasted G1 Therapeutics Price: 2.35. Negative monthly dynamics of the instrument is expected with 27.820% volatility is expected.

Pessimistic forecast: 1.89

Optimistic: 2.62


G1 Therapeutics stock forecast for Jun 2026.
Estimated Average Forecasted G1 Therapeutics Price: 2.35. Negative monthly dynamics of the instrument is expected with 29.348% volatility is expected.

Pessimistic forecast: 2.00

Optimistic: 2.83


G1 Therapeutics stock forecast for Jul 2026.
Estimated Average Forecasted G1 Therapeutics Price: 2.64. Positive monthly dynamics of the instrument is expected with 14.949% volatility is expected.

Pessimistic forecast: 2.43

Optimistic: 2.86


G1 Therapeutics stock forecast for Aug 2026.
Estimated Average Forecasted G1 Therapeutics Price: 2.65. Positive monthly dynamics of the instrument is expected with 19.337% volatility is expected.

Pessimistic forecast: 2.33

Optimistic: 2.89


G1 Therapeutics stock forecast for Sep 2026.
Estimated Average Forecasted G1 Therapeutics Price: 2.38. Negative monthly dynamics of the instrument is expected with 27.333% volatility is expected.

Pessimistic forecast: 2.03

Optimistic: 2.80


G1 Therapeutics stock forecast for Oct 2026.
Estimated Average Forecasted G1 Therapeutics Price: 2.63. Positive monthly dynamics of the instrument is expected with 25.763% volatility is expected.

Pessimistic forecast: 2.35

Optimistic: 3.17


G1 Therapeutics stock forecast for Nov 2026.
Estimated Average Forecasted G1 Therapeutics Price: 2.39. Negative monthly dynamics of the instrument is expected with 15.409% volatility is expected.

Pessimistic forecast: 2.20

Optimistic: 2.60


G1 Therapeutics stock forecast for Dec 2026.
Estimated Average Forecasted G1 Therapeutics Price: 2.43. Positive monthly dynamics of the instrument is expected with 24.512% volatility is expected.

Pessimistic forecast: 2.13

Optimistic: 2.82



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 98.46 (27.03.2023) 0.42 %
AbbVie Inc.
ABBV 157.54 (27.03.2023) -0.30 %
Aeterna Zentaris Inc.
AEZS 2.63 (27.03.2023) -0.38 %
Allakos Inc.
ALLK 4.55 (27.03.2023) -1.30 %
Allogene Therapeutics, Inc.
ALLO 5.03 (27.03.2023) 0.20 %
Amgen Inc.
AMGN 236.76 (27.03.2023) -0.53 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 2.97 (27.03.2023) 3.48 %
Aurora Cannabis Inc.
ACB 0.7074 (27.03.2023) 0.41 %
Becton Dickinson and Company
BDX 242.18 (27.03.2023) 0.70 %
Biogen Inc.
BIIB 269.98 (27.03.2023) -0.02 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 14.29 (24.03.2023) 6.64 %
BioNTech SE
BNTX 123.6 (27.03.2023) -3.59 %
bluebird bio, Inc.
BLUE 4.51 (27.03.2023) 1.81 %
Boston Scientific Corp.
BSX 48.33 (27.03.2023) 0.23 %
Bristol-Myers Squibb Company
BMY 68.07 (27.03.2023) 0.58 %
Canopy Growth Corp.
CGC 1.88 (27.03.2023) -1.05 %
Castle Biosciences, Inc.
CSTL 22.63 (27.03.2023) 0.53 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 8.86 (27.03.2023) 9.38 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 2.79 (27.03.2023) 8.56 %
Gilead Sciences, Inc.
GILD 79.58 (27.03.2023) -0.52 %
GlaxoSmithKline plc
GSK 35.04 (27.03.2023) 1.92 %
GoodRx Holdings, Inc.
GDRX 6.15 (27.03.2023) -3.61 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 70.81 (27.03.2023) 0.83 %
Inovio Pharmaceuticals, Inc.
INO 0.9137 (27.03.2023) -5.07 %
Johnson & Johnson
JNJ 153.3 (27.03.2023) 0.43 %
Medtronic plc.
MDT 79.64 (27.03.2023) 0.34 %
Merck & Co., Inc.
MRK 106.93 (27.03.2023) 2.03 %
Moderna, Inc.
MRNA 148.35 (27.03.2023) -1.68 %
Novartis AG
NVS 90.28 (27.03.2023) 8.00 %
Novavax, Inc.
NVAX 6.09 (27.03.2023) 0.83 %
ObsEva SA
OBSV 0.08 (27.03.2023) -21.41 %
OrganiGram Holdings Inc.
OGI 0.644 (27.03.2023) 1.77 %
Pfizer Inc.
PFE 40.22 (27.03.2023) -0.42 %
Regeneron Pharmaceuticals, Inc.
REGN 820.41 (27.03.2023) 0.05 %
Sanofi
SNY 53.22 (27.03.2023) 1.16 %
Schrodinger, Inc.
SDGR 25.62 (27.03.2023) 0.20 %
Senseonics Holdings, Inc.
SENS 0.7103 (27.03.2023) -0.71 %
Sorrento Therapeutics, Inc.
SRNE 0.3251 (27.03.2023) -4.38 %
Stryker Corp.
SYK 278.11 (27.03.2023) 0.51 %
Sundial Growers Inc.
SNDL 1.545 (27.03.2023) -1.59 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.73 (27.03.2023) 3.44 %
Thermo Fisher Scientific Inc.
TMO 561.69 (27.03.2023) 0.61 %
Tilray, Inc.
TLRY 2.61 (27.03.2023) -0.38 %
UnitedHealth Group, Inc.
UNH 481.9 (27.03.2023) 1.24 %
Veeva Systems Inc.
VEEV 177.54 (27.03.2023) 1.12 %
Zomedica Corp.
ZOM 0.21 (27.03.2023) 0.00 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.41 (27.03.2023) -4.70 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.